Indaptus Therapeutics, Inc.
Indaptus Therapeutics, Inc. (INDP) is a publicly traded company in the Unknown sector. Across all available filings, 8 corporate insiders have executed 27 transactions totaling $592.9K, demonstrating a bullish sentiment with $392.9K in net insider flow. The most recent transaction on Jan 20, 2026 involved a transaction of 25,000 shares valued at $0.
INDP Insider Activity Summary
Who Is Buying INDP Stock?
No significant insider buying has been recorded for INDP in the recent period.
Who Is Selling INDP Stock?
No significant insider selling has been recorded for INDP in the recent period.
Is Indaptus Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for INDP is bullish with an Insider Alignment Score of 83/100 and a net flow of $392.9K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
INDP Frequently Asked Questions
Understanding INDP Insider Activity
Insider trading at Indaptus Therapeutics, Inc. (INDP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 8 insiders are actively trading INDP stock, having executed 27 transactions in the past 90 days. The most active insider is Jeffrey A. Meckler (Executive), who has made 11 transactions totaling $919.1K.
Related Tools
Track Indaptus Therapeutics, Inc. Insider Activity
Get notified when executives and directors at INDP file new Form 4 transactions